Physician profile
Benjamin Alan Collins
NPI 1720422207
$10,135.65
in general payments reported to CMS, 2019-2025
17 companies · $1,310 in 2025
The $1,310 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,040 · 2020: $241 · 2021: $3,442 · 2022: $580 · 2023: $781 · 2024: $742 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,833.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $6,467.07 | 2019-2022 | |
| Genzyme Corporation | $595.79 | 2019-2025 | |
| Stryker Corporation | $589.10 | 2019-2025 | Scopis Ent |
| Regeneron Healthcare Solutions, INC. | $390.77 | 2020-2025 | Dupixent |
| Integra Lifesciences Corporation | $344.47 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $325.15 | 2024-2025 | |
| Medtronic, INC. | $325.10 | 2023-2025 | Propel, Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $302.05 | 2023-2025 | Inspire |
| Optinose US, INC. | $265.30 | 2019-2025 | |
| Glaxosmithkline, LLC. | $198.45 | 2022-2025 | Nucala |
| Paratek Pharmaceuticals, INC. | $115.76 | 2025 | Nuzyra |
| Smith+Nephew, INC. | $79.86 | 2022-2023 | Grafix |
| Neurent Medical Limited | $34.37 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Merck Sharp & Dohme LLC | $32.28 | 2021-2023 | |
| Acclarent, INC | $28.85 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $22.06 | 2024 | |
| Sanofi-Aventis U.S. LLC | $19.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.